Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Christina Gros"'
Autor:
Dante Rotili, Domenico Tarantino, Biagina Marrocco, Christina Gros, Véronique Masson, Valérie Poughon, Fréderic Ausseil, Yanqi Chang, Donatella Labella, Sandro Cosconati, Salvatore Di Maro, Ettore Novellino, Michael Schnekenburger, Cindy Grandjenette, Celine Bouvy, Marc Diederich, Xiaodong Cheng, Paola B Arimondo, Antonello Mai
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96941 (2014)
Chemical manipulations performed on the histone H3 lysine 9 methyltransferases (G9a/GLP) inhibitor BIX-01294 afforded novel desmethoxyquinazolines able to inhibit the DNA methyltransferase DNMT3A at low micromolar levels without any significant inhib
Externí odkaz:
https://doaj.org/article/281a01d650e04497b3316ad698b79eb4
Autor:
Samy Cecioni, Roger A. Ashmus, Pierre-André Gilormini, Sha Zhu, Xi Chen, Xiaoyang Shan, Christina Gros, Matthew C. Deen, Yang Wang, Robert Britton, David J. Vocadlo
Publikováno v:
Nature Chemical Biology. 18:332-341
Understanding the function and regulation of enzymes within their physiologically relevant milieu requires quality tools that report on their cellular activities. Here we describe a strategy for glycoside hydrolases that overcomes several limitations
Autor:
Clemens Zwergel, Michael Schnekenburger, Federica Sarno, Cecilia Battistelli, Maria Cristina Manara, Giulia Stazi, Roberta Mazzone, Rossella Fioravanti, Christina Gros, Frédéric Ausseil, Cristina Florean, Angela Nebbioso, Raffaele Strippoli, Toshikazu Ushijima, Katia Scotlandi, Marco Tripodi, Paola B. Arimondo, Lucia Altucci, Marc Diederich, Antonello Mai, Sergio Valente
Publikováno v:
Clinical Epigenetics. 14
Autor:
Matthew C. Deen, Yanping Zhu, Christina Gros, Na Na, Pierre-André Gilormini, David L. Shen, Sandeep Bhosale, Nadia Anastasi, RuiQi Wang, Xiaoyang Shan, Eva Harde, Ravi Jagasia, Francis C. Lynn, David J. Vocadlo
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Loss of activity of the lysosomal glycosidase β-glucocerebrosidase (GCase) causes the lysosomal storage disease Gaucher disease (GD) and has emerged as the greatest genetic risk factor for the development of both Parkinson disease (PD) and dementia
Autor:
Emma V. Parkins, Darrin H. Brager, Jeffrey K. Rymer, John M. Burwinkel, Diego Rojas, Durgesh Tiwari, Yueh-Chiang Hu, Christina Gross
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract MicroRNAs are an emerging class of synaptic regulators. These small noncoding RNAs post-transcriptionally regulate gene expression, thereby altering neuronal pathways and shaping cell-to-cell communication. Their ability to rapidly alter gen
Externí odkaz:
https://doaj.org/article/07598c5410004486bbda98f3ddb1749f
Autor:
Adam McCluskey, Hong‐Yee Tan, Richard W. Meek, Gontran Sangouard, Matthew G. Alteen, David A. Cardoso, Gideon J. Davies, Cecilia C. Russell, Matthew C. Deen, Phillip J. Robinson, David L. Shen, David J. Vocadlo, Jil A. Busmann, Christina Gros
Glycosyltransferases carry out important cellular functions in species ranging from bacteria to humans. Despite their essential roles in biology, simple and robust activity assays that can be easily applied to high-throughput screening for inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ae43c5b3b52190baf080b2c0a17ff1
https://eprints.whiterose.ac.uk/159729/1/Accepted_Article_Alteen_Manuscript_Feb22.pdf
https://eprints.whiterose.ac.uk/159729/1/Accepted_Article_Alteen_Manuscript_Feb22.pdf
Autor:
Sabine Felser, Julia Rogahn, Änne Glass, Lars Arne Bonke, Daniel Fabian Strüder, Jana Stolle, Susann Schulze, Markus Blaurock, Ursula Kriesen, Christian Junghanss, Christina Grosse-Thie
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0301304 (2024)
IntroductionPatients with head and neck cancer (PwHNC) benefit from targeted exercise interventions: symptom relief, compensation for dysfunction, improvement in quality of life (QoL). Data on acceptance physical interventions in PwHNC are rare. The
Externí odkaz:
https://doaj.org/article/e402af1068c841ddbe42dbff3e803421
Autor:
Larissa Henze, Luise Grunwald, Sabine Felser, Maria Witte, Christina Grosse-Thie, Catrin Roolf, Hugo Murua Escobar, Christian Junghanss
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
BackgroundAbdominal venous thromboses are rare thrombotic events with heterogeneous etiologies. They are related to myeloproliferative neoplasms (MPNs) in some patients and can occur as first signs of the disease. MPNs are characterized by mutations
Externí odkaz:
https://doaj.org/article/b50c2e711dcc4d15b77595056f66121d
Autor:
Michael J. McGlinchey, Pascal Pigeon, Gérard Jaouen, Meral Görmen, Yong Wang, Franck Martial, Anne Vessières, Christina Gros, Siden Top
Publikováno v:
European Journal of Inorganic Chemistry
European Journal of Inorganic Chemistry, Wiley-VCH Verlag, 2017, Special Issue: The Multifaceted Chemistry of Ferrocene (Cluster Issue), pp.454-465. ⟨10.1002/ejic.201601088⟩
European Journal of Inorganic Chemistry, Wiley-VCH Verlag, 2017, Special Issue: The Multifaceted Chemistry of Ferrocene (Cluster Issue), pp.454-465. ⟨10.1002/ejic.201601088⟩
International audience; As part of our ongoing study of the toxicity of compounds derived from 1,1-bis(4-hydroxyphenyl)-2-ferrocenylbut-1-ene, we have recently shown that closely analogous [3]ferrocenophane complexes have an in vitro toxicity level s
Autor:
Yoann Menon, Christina Gros, Philippe Schambel, Véronique Masson, Paola B. Arimondo, Alexandre Erdmann, Yannick Aussagues, Michel Baltas, Frédéric Ausseil, Natacha Novosad
Publikováno v:
Future Medicinal Chemistry
Future Medicinal Chemistry, 2016, 8 (4), pp.373-380. ⟨10.4155/fmc.15.192⟩
Future Medicinal Chemistry, Future Science, 2016, 8 (4), pp.373-380. ⟨10.4155/fmc.15.192⟩
Future Medicinal Chemistry, 2016, 8 (4), pp.373-380. ⟨10.4155/fmc.15.192⟩
Future Medicinal Chemistry, Future Science, 2016, 8 (4), pp.373-380. ⟨10.4155/fmc.15.192⟩
DNA methylation is the most studied epigenetic event. Since the methylation profile of the genome is widely modified in cancer cells, DNA methyltransferases are the target of new anticancer therapies. Nucleosidic inhibitors suffer from toxicity and c